CCR4 Rabbit Monoclonal Antibody [Clone ID: KW-0761 (Mogamulizumab)]
CAT#: TA386079
Recombinant Anti-CCR4 (Clone KW-0761 (Mogamulizumab))
Need it in bulk or conjugated? 
                            Get a free quote
                        
CNY 7170.00
货期*
                        6周
                    规格
                        
                         推荐一起购买 (1)
                    
                    
                                        beta Actin Mouse Monoclonal Antibody, Clone OTI1, Loading Control
                                    
                                
                                                
                                                
                                                
                                                    CNY 300.00 
                                                    
                                                    CNY 1430.00
                                                
                                            
Specifications
| Product Data | |
| Clone Name | KW-0761 (Mogamulizumab) | 
| Reactivity | Human | 
| Host | Rabbit | 
| Clonality | Monoclonal | 
| Immunogen | This antibody was prepared by humanization of a mouse anti-CCR4 mAb. | 
| Specificity | This antibody is specific for human CCR4, a chemokine receptor that is preferentially expressed by Th2 and regulatory T (Treg) cells. CCR4 is also detected on basophils, platelets, monocytes and brain microvascular and coronary artery endothelial cells. The clinically used format of this antibody (which underwent additional de-fucosylation to increase antibody-dependent cellular cytotoxicity (ADCC)), has significant clinical activity in heavily pretreated patients with mycosis fungoides and Sézary syndrome, and is associated with an overall response rate of 36.8% and a median duration of response of 10.4 months (Duvic et al, 2014). It was shown to CCR4-expressing cells by antibody-dependent, cell-mediated cytotoxicity (ADCC). Therapeutically, this results in a dual mechanism of action; in addition to directly targeting malignant T cells over-expressing CCR4, this antibody also depletes T reg cells, an important therapeutic target in human cancers. This antibody is well-tolerated, and administration does not appear to trigger clinically significant autoimmune complications in phase 1/2 trials (Duvic et al, 2014). This antibody has been approved in Japan for the treatment of relapsed or refractory adult T-cell leukemia/lymphoma, and is in clinical trials for solid cancers. For the avoidance of doubt - the material produced by Absolute Antibody has not been de-fucosylated.  | 
        
| Isotype | IgG, kappa | 
| Formulation | PBS with 0.02% Proclin 300. | 
| Concentration | lot specific | 
| Conjugation | Unconjugated | 
| Storage Condition | Please store at 4°C for up to 3 months. For longer storage, aliquot and store at -20°C. Avoid freeze and thaw cycles. | 
| Gene Name | C-C motif chemokine receptor 4 | 
| Database Link | |
| Synonyms | CC-CKR-4; CCR-4; CD194; ChemR13; CKR4; CMKBR4; HGCN:14099; k5-5; MGC88293 | 
| Note | This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. | 
| Reference Data | |
Documents
| Product Manuals | 
| FAQs | 
| SDS | 
Resources
| 抗体相关资料 | 
                         Customer
                                Reviews 
                    
                    
                                Loading...
                            
                        